Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes
Abstract The link between cardiometabolic markers and hepatic steatosis and liver fibrosis in non-hypertensive, non-diabetic populations remains unclear. A study was conducted using data from the National Health and Nutrition Examination Survey. Hepatic steatosis and liver fibrosis were assessed usi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01003-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728269654425600 |
|---|---|
| author | Zhixing Fan Chaojun Yang Xiaojing Zhao Jing Zhang |
| author_facet | Zhixing Fan Chaojun Yang Xiaojing Zhao Jing Zhang |
| author_sort | Zhixing Fan |
| collection | DOAJ |
| description | Abstract The link between cardiometabolic markers and hepatic steatosis and liver fibrosis in non-hypertensive, non-diabetic populations remains unclear. A study was conducted using data from the National Health and Nutrition Examination Survey. Hepatic steatosis and liver fibrosis were assessed using vibration-controlled transient elastography. Logistic regression and restricted cubic splines (RCS) were used to evaluate the associations of cardiometabolic index (CMI), atherogenic index of plasma (AIP), triglyceride-glucose index (TyG), and estimated glucose disposal rate (eGDR) on hepatic steatosis and estimated fibrosis. Mediation analysis examined the role of insulin resistance (HOMA-IR) and liver enzymes. Among 1489 participants, 39.15% had hepatic steatosis and 2.82% had liver fibrosis. Higher CMI (OR = 3.967, 95%CI: 2.297, 6.851), AIP (OR = 3.255, 95%CI: 2.031, 5.216), TyG (OR = 3.689, 95%CI: 2.363, 5.760), and FLI (OR = 2.695, 95%CI: 1.997, 7.816) tertiles of Q3 were linked to increased hepatic steatosis odds, while eGDR reduced odds (OR = 0.217, 95%CI: 0.127, 0.373). The AUC values of these four cardiac markers were greater than FLI, among which eGDR showed the highest predictive value (AUC = 0.781). In the hepatic steatosis population, CMI (OR = 1.419, 95%CI: 1.033, 2.747), AIP (OR = 5.527, 95%CI: 1.082, 28.242), and TyG (OR = 2.345, 95%CI: 1.180, 4.661) were also showed significant association with liver fibrosis, while eGDR and FIB-4 were not associated with liver fibrosis. AIP had the highest discriminative ability for liver fibrosis (AUC = 0.798). Mediation analysis showed HOMA-IR mediated 25.50%~36.20% of cardiometabolic markers’ associations with hepatic steatosis, followed by liver enzymes. Cardiometabolic markers are strongly linked to hepatic steatosis and liver fibrosis in populations without traditional risk factors, even outperforming the established hepatic steatosis and the fibrosis marker, highlighting their potential for early liver disease risk identification in seemingly healthy individuals. |
| format | Article |
| id | doaj-art-ec0be15bec7144ef8d1d7a62f80de487 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-ec0be15bec7144ef8d1d7a62f80de4872025-08-20T03:09:35ZengNature PortfolioScientific Reports2045-23222025-05-0115111210.1038/s41598-025-01003-4Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetesZhixing Fan0Chaojun Yang1Xiaojing Zhao2Jing Zhang3Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges UniversityDepartment of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges UniversitySchoolof Foreign Stdies, China Three Gorges·UniversityThe Second Department of Infectious Disease, Shanghai Fifth People’s Hospital, Fudan UniversityAbstract The link between cardiometabolic markers and hepatic steatosis and liver fibrosis in non-hypertensive, non-diabetic populations remains unclear. A study was conducted using data from the National Health and Nutrition Examination Survey. Hepatic steatosis and liver fibrosis were assessed using vibration-controlled transient elastography. Logistic regression and restricted cubic splines (RCS) were used to evaluate the associations of cardiometabolic index (CMI), atherogenic index of plasma (AIP), triglyceride-glucose index (TyG), and estimated glucose disposal rate (eGDR) on hepatic steatosis and estimated fibrosis. Mediation analysis examined the role of insulin resistance (HOMA-IR) and liver enzymes. Among 1489 participants, 39.15% had hepatic steatosis and 2.82% had liver fibrosis. Higher CMI (OR = 3.967, 95%CI: 2.297, 6.851), AIP (OR = 3.255, 95%CI: 2.031, 5.216), TyG (OR = 3.689, 95%CI: 2.363, 5.760), and FLI (OR = 2.695, 95%CI: 1.997, 7.816) tertiles of Q3 were linked to increased hepatic steatosis odds, while eGDR reduced odds (OR = 0.217, 95%CI: 0.127, 0.373). The AUC values of these four cardiac markers were greater than FLI, among which eGDR showed the highest predictive value (AUC = 0.781). In the hepatic steatosis population, CMI (OR = 1.419, 95%CI: 1.033, 2.747), AIP (OR = 5.527, 95%CI: 1.082, 28.242), and TyG (OR = 2.345, 95%CI: 1.180, 4.661) were also showed significant association with liver fibrosis, while eGDR and FIB-4 were not associated with liver fibrosis. AIP had the highest discriminative ability for liver fibrosis (AUC = 0.798). Mediation analysis showed HOMA-IR mediated 25.50%~36.20% of cardiometabolic markers’ associations with hepatic steatosis, followed by liver enzymes. Cardiometabolic markers are strongly linked to hepatic steatosis and liver fibrosis in populations without traditional risk factors, even outperforming the established hepatic steatosis and the fibrosis marker, highlighting their potential for early liver disease risk identification in seemingly healthy individuals.https://doi.org/10.1038/s41598-025-01003-4Cardiometabolic indexAtherogenic index of plasmaTriglyceride-glucose indexEstimated glucose disposal rateHepatic steatosisLiver fibrosis |
| spellingShingle | Zhixing Fan Chaojun Yang Xiaojing Zhao Jing Zhang Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes Scientific Reports Cardiometabolic index Atherogenic index of plasma Triglyceride-glucose index Estimated glucose disposal rate Hepatic steatosis Liver fibrosis |
| title | Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| title_full | Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| title_fullStr | Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| title_full_unstemmed | Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| title_short | Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| title_sort | association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes |
| topic | Cardiometabolic index Atherogenic index of plasma Triglyceride-glucose index Estimated glucose disposal rate Hepatic steatosis Liver fibrosis |
| url | https://doi.org/10.1038/s41598-025-01003-4 |
| work_keys_str_mv | AT zhixingfan associationofcardiometabolicmarkerswithhepaticsteatosisandliverfibrosisinpopulationwithoutobesityanddiabetes AT chaojunyang associationofcardiometabolicmarkerswithhepaticsteatosisandliverfibrosisinpopulationwithoutobesityanddiabetes AT xiaojingzhao associationofcardiometabolicmarkerswithhepaticsteatosisandliverfibrosisinpopulationwithoutobesityanddiabetes AT jingzhang associationofcardiometabolicmarkerswithhepaticsteatosisandliverfibrosisinpopulationwithoutobesityanddiabetes |